The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

R. A. Wilke, L. B. Ramsey, S. G. Johnson, W. D. Maxwell, H. L. McLeod, D. Voora, R. M. Krauss, D. M. Roden, Q. Feng, R. M. Cooper-DeHoff, L. Gong, T. E. Klein, M. Wadelius, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume92
Issue number1
Pages (from-to)112-117
Number of pages6
ISSN0009-9236
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • STATIN-ASSOCIATED MYOPATHY
  • HIGH-RISK INDIVIDUALS
  • OATP-C
  • PLASMA-CONCENTRATIONS
  • CONTROLLED-TRIAL
  • PHARMACOKINETICS
  • RHABDOMYOLYSIS
  • ROSUVASTATIN
  • VARIANTS
  • DRUG
  • 317 Pharmacy

Cite this

Wilke, R. A. ; Ramsey, L. B. ; Johnson, S. G. ; Maxwell, W. D. ; McLeod, H. L. ; Voora, D. ; Krauss, R. M. ; Roden, D. M. ; Feng, Q. ; Cooper-DeHoff, R. M. ; Gong, L. ; Klein, T. E. ; Wadelius, M. ; Niemi, Mikko. / The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy. In: Clinical Pharmacology and Therapeutics. 2012 ; Vol. 92, No. 1. pp. 112-117.
@article{692d72ec06534fb0a897bb362241dfa8,
title = "The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy",
keywords = "STATIN-ASSOCIATED MYOPATHY, HIGH-RISK INDIVIDUALS, OATP-C, PLASMA-CONCENTRATIONS, CONTROLLED-TRIAL, PHARMACOKINETICS, RHABDOMYOLYSIS, ROSUVASTATIN, VARIANTS, DRUG, 317 Pharmacy",
author = "Wilke, {R. A.} and Ramsey, {L. B.} and Johnson, {S. G.} and Maxwell, {W. D.} and McLeod, {H. L.} and D. Voora and Krauss, {R. M.} and Roden, {D. M.} and Q. Feng and Cooper-DeHoff, {R. M.} and L. Gong and Klein, {T. E.} and M. Wadelius and Mikko Niemi",
year = "2012",
doi = "10.1038/clpt.2012.57",
language = "English",
volume = "92",
pages = "112--117",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "1",

}

Wilke, RA, Ramsey, LB, Johnson, SG, Maxwell, WD, McLeod, HL, Voora, D, Krauss, RM, Roden, DM, Feng, Q, Cooper-DeHoff, RM, Gong, L, Klein, TE, Wadelius, M & Niemi, M 2012, 'The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy', Clinical Pharmacology and Therapeutics, vol. 92, no. 1, pp. 112-117. https://doi.org/10.1038/clpt.2012.57

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy. / Wilke, R. A.; Ramsey, L. B.; Johnson, S. G.; Maxwell, W. D.; McLeod, H. L.; Voora, D.; Krauss, R. M.; Roden, D. M.; Feng, Q.; Cooper-DeHoff, R. M.; Gong, L.; Klein, T. E.; Wadelius, M.; Niemi, Mikko.

In: Clinical Pharmacology and Therapeutics, Vol. 92, No. 1, 2012, p. 112-117.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

AU - Wilke, R. A.

AU - Ramsey, L. B.

AU - Johnson, S. G.

AU - Maxwell, W. D.

AU - McLeod, H. L.

AU - Voora, D.

AU - Krauss, R. M.

AU - Roden, D. M.

AU - Feng, Q.

AU - Cooper-DeHoff, R. M.

AU - Gong, L.

AU - Klein, T. E.

AU - Wadelius, M.

AU - Niemi, Mikko

PY - 2012

Y1 - 2012

KW - STATIN-ASSOCIATED MYOPATHY

KW - HIGH-RISK INDIVIDUALS

KW - OATP-C

KW - PLASMA-CONCENTRATIONS

KW - CONTROLLED-TRIAL

KW - PHARMACOKINETICS

KW - RHABDOMYOLYSIS

KW - ROSUVASTATIN

KW - VARIANTS

KW - DRUG

KW - 317 Pharmacy

U2 - 10.1038/clpt.2012.57

DO - 10.1038/clpt.2012.57

M3 - Article

VL - 92

SP - 112

EP - 117

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -